ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,043	3,053	5,140	2,578	3,752	8,499
Market Cap Growth	41.29%	-40.60%	99.40%	-31.29%	-55.85%	28.98%
Enterprise Value	3,251	2,537	4,852	2,204	3,278	7,904
Last Close Price	23.90	18.35	31.31	15.92	23.34	53.46
PE Ratio	15.51	13.48	-	-	-	-
Forward PE	35.48	35.90	27.40	-	-	-
PS Ratio	3.82	3.19	7.08	4.98	7.75	19.24
PB Ratio	4.41	4.17	11.91	6.44	6.94	13.56
P/TBV Ratio	5.02	4.98	14.04	6.44	6.94	13.58
P/FCF Ratio	20.44	19.42	308.70	-	-	-
P/OCF Ratio	20.32	19.36	307.78	-	-	-
EV/Sales Ratio	3.10	2.65	6.68	4.26	6.77	17.89
EV/EBITDA Ratio	29.98	25.33	-	-	-	-
EV/EBIT Ratio	34.44	30.11	-	-	-	-
EV/FCF Ratio	16.44	16.14	291.36	-	-	-
Debt / Equity Ratio	0.06	0.07	0.13	0.16	0.12	0.08
Debt / EBITDA Ratio	0.45	0.47	-	-	-	-
Debt / FCF Ratio	0.28	0.33	3.44	-	-	-
Asset Turnover	0.91	0.99	1.09	0.80	0.65	0.56
Inventory Turnover	9.53	13.33	18.53	51.22	29.44	35.81
Quick Ratio	2.77	2.18	2.13	3.82	6.10	6.44
Current Ratio	3.02	2.38	2.42	4.04	6.43	6.77
Return on Equity (ROE)	34.95%	38.89%	-14.73%	-45.89%	-28.75%	-42.47%
Return on Assets (ROA)	5.11%	5.44%	-6.86%	-21.70%	-14.37%	-18.66%
Return on Capital (ROIC)	7.38%	8.27%	-9.64%	-26.18%	-16.62%	-21.09%
Return on Capital Employed (ROCE)	9.70%	10.60%	-14.80%	-48.40%	-28.20%	-34.60%
Earnings Yield	6.46%	7.42%	-1.19%	-8.38%	-4.47%	-3.31%
FCF Yield	4.89%	5.15%	0.32%	-4.42%	-3.38%	-1.69%
Buyback Yield / Dilution	-1.70%	-1.55%	-1.32%	-0.74%	-2.01%	-6.88%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q